Literature DB >> 11450016

Brain oxygen tension during hyperoxia in a swine model of cerebral ischaemia.

S Rossi1, L Longhi, M Balestreri, D Spagnoli, A deLeo, N Stocchetti.   

Abstract

UNLABELLED: Arterial hyperoxia improves oxygen tension measured into the cerebral tissue (ptiO2). The extent of this improvement in ameliorating O2 delivery to the cerebral tissue, when cerebral blood flow (CBF) is reduced, is still unclear. The present experiment was developed to investigate the effect of arterial hyperoxia at normal or reduced CBF (baseline, CBF = 50-60%, and CBF = 20-30% of the baseline). CBF reduction was achieved in 7 pigs by saline infusion in a lateral ventricle. PtiO2 was measured by Licox equipment. Arterovenous oxygen difference (AVDO2) was calculated as the difference between arterial oxygen content and superior sagittal sinus oxygen content. Hyperoxia was induced by increasing inspired oxygen fraction to 100%. PtiO2 moved respectively from 27.95 (+/- 10.15) to 45.98 (+/- 15.31), from 14.77 (+/- 3.58) to 30.71 (+/- 12.2), and from 3.45 (+/- 2.89) to 11.1 (+/- 12.6) mmHg at normal CBF, after the first reduction and after the second reduction. O2 supply showed only a negligible increase. AVDO2 decreased during the phases of intact and moderate CBF impairment, while it did not change during the phase of severe CBF impairment. IN
CONCLUSION: an increase of ptiO2 does not necessarily correspond to an improvement of brain oxygen delivery. The small increase in oxygen delivery due to hyperoxia may cause a slight improvement in the balance between O2 delivery and consumption during mild CBF reduction, but such improvement is negligible when severe CBF reduction occurs.

Entities:  

Mesh:

Year:  2000        PMID: 11450016     DOI: 10.1007/978-3-7091-6346-7_49

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  8 in total

1.  Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome.

Authors:  A Agren-Wilsson; A Eklund; L-O D Koskinen; A T Bergenheim; J Malm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

2.  Brain tissue oxygen monitoring in intracerebral hemorrhage.

Authors:  J Claude Hemphill; Diane Morabito; Mary Farrant; Geoffrey T Manley
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 3.  Hyperoxia: good or bad for the injured brain?

Authors:  Michael N Diringer
Journal:  Curr Opin Crit Care       Date:  2008-04       Impact factor: 3.687

Review 4.  NADPH oxidases as therapeutic targets in ischemic stroke.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

5.  Admission oxygenation and ventilation parameters associated with discharge survival in severe pediatric traumatic brain injury.

Authors:  Vijay Kumar Ramaiah; Deepak Sharma; Li Ma; Sumidtra Prathep; Noah G Hoffman; Monica S Vavilala
Journal:  Childs Nerv Syst       Date:  2012-12-04       Impact factor: 1.475

6.  Relationship of common hemodynamic and respiratory target parameters with brain tissue oxygen tension in the absence of hypoxemia or hypotension after cardiac arrest: A post-hoc analysis of an experimental study using a pig model.

Authors:  Yong Hun Jung; Kamoljon Shamsiev; Najmiddin Mamadjonov; Kyung Woon Jeung; Hyoung Youn Lee; Byung Kook Lee; Byung Soo Kang; Tag Heo; Yong Il Min
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

7.  Brain tissue oxygen monitoring identifies cortical hypoxia and thalamic hyperoxia after experimental cardiac arrest in rats.

Authors:  Mioara D Manole; Patrick M Kochanek; Hülya Bayır; Henry Alexander; Cameron Dezfulian; Ericka L Fink; Michael J Bell; Robert S B Clark
Journal:  Pediatr Res       Date:  2013-11-13       Impact factor: 3.756

Review 8.  Hyperoxia toxicity after cardiac arrest: What is the evidence?

Authors:  Jean-François Llitjos; Jean-Paul Mira; Jacques Duranteau; Alain Cariou
Journal:  Ann Intensive Care       Date:  2016-03-22       Impact factor: 6.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.